Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
about
Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst.The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: comparisons, contrasts, and aspirin confoundingSafety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugsEffects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.Disturbance of peristalsis in the guinea-pig isolated small intestine by indomethacin, but not cyclo-oxygenase isoform-selective inhibitorsNitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathwaysMechanism of allosteric activation of TMEM16A/ANO1 channels by a commonly used chloride channel blockerIdentification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolyticaLow endotoxemia prevents the reduction of gastric blood flow induced by NSAIDs: role of nitric oxide.Preferential uptake of the non steroid anti-inflammatory drug diclofenac into inflamed tissues after a single oral dose in ratsIn situ click chemistry generation of cyclooxygenase-2 inhibitors.Enhancement of antinociception by coadministration of minocycline and a non-steroidal anti-inflammatory drug indomethacin in naïve mice and murine models of LPS-induced thermal hyperalgesia and monoarthritisRole of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle.Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis.NMI-1182, a gastro-protective cyclo-oxygenase-inhibiting nitric oxide donor.Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the ratMaximizing the safety of nonsteroidal anti-inflammatory drug use for postoperative dental pain: an evidence-based approach.In Silico Analysis of the Potential of the Active Compounds Fucoidan and Alginate Derived from Sargassum Sp. as Inhibitors of COX-1 and COX-2Silibinin treatment prevents endotoxin-induced uveitis in rats in vivo and in vitro.Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols.Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugsA comparative evaluation of the effect of diclofenac sodium with and without per-orally administered methylprednisolone on the sequelae of impacted mandibular third molar removal: A cohort randomized double-blind clinical trial.Apoptosis pathways as promising targets for skin cancer therapy.The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs).Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia2-(5-Meth-oxy-2-methyl-1H-indol-3-yl)-N'-[(1E,2E)-3-phenyl-prop-2-en-1-yl-idene]acetohydrazide.Mechanisms of coronary microvascular adaptation to obesity.COX inhibitors for airway inflammation.Insights into the effects of diclofenac and other non-steroidal anti-inflammatory agents on ion channels.Pharmacokinetics, pharmacodynamics, toxicology and therapeutics of mavacoxib in the dog: a review.A novel NSAID derivative, phospho-ibuprofen, prevents AOM-induced colon cancer in rats.Stability of diclofenac sodium oral suspensions packaged in amber polyvinyl chloride bottles.Comparison of the anti-inflammatory and analgesic effects in rats of diclofenac-sodium, felbinac and indomethacin patches.Effects of acetyl salycilic acid and ibuprofen in chronic liver damage induced by CCl4.Molecular Dynamic Screening Sesquiterpenoid Pogostemon Herba as Suggested Cyclooxygenase Inhibitor.The anti-inflammatory action of the analgesic kyotorphin neuropeptide derivatives: insights of a lipid-mediated mechanism.Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway.The low molecular weight fraction of human serum albumin upregulates COX2, prostaglandin E2, and prostaglandin D2 under inflammatory conditions in osteoarthritic knee synovial fibroblasts.Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis in rats.
P2860
Q24536027-D7118E77-8A65-4553-A24E-2104B53EB334Q24796000-6B9D7278-C829-4514-A1B6-B005BB65155CQ28177082-D447A881-B5D3-4598-AB18-1C94FA11F34EQ28192717-078E16BF-3CA7-4C08-AD9B-7005435ED0ABQ28194198-A7905D7E-9867-45AE-B3F8-F26080D1D922Q28360204-EBB278AE-D3C8-4E69-8118-183A366D600BQ28362066-806D6922-C79A-4ACE-A8B8-8924D714282BQ28601949-4038B61B-1C83-4669-8079-A80F8C828EF2Q30449610-672CE0CB-16DE-4F58-B17A-4801312B0793Q31143606-E205664A-2185-4821-96C8-9F078FCFA948Q33418770-25D4B32C-55D2-4591-8D71-ECB917B9FB66Q33687262-255965F4-398C-43DA-9A7C-894A840D8607Q33759886-7E749C53-D2C2-450A-B1E9-2DDD06D8BB69Q33934368-60EC96B2-0744-47A2-AA6B-E6536F60E7B5Q34449825-11A95242-F079-4F28-84B2-0C7767AE111DQ34464035-E4093ABF-0EA4-46EE-AE34-DF09608473E8Q35044483-891DE798-D079-48EE-B171-37E8F516E716Q35179307-5B6BC3F0-C88F-4281-B432-E4B1E9122A63Q36122973-5BC062B5-AA66-4907-8F95-C26D5FFA8F4CQ36334208-9E303040-B860-46BB-8CCE-FC5A75838332Q36610393-32642288-F9DC-487A-980D-00E7426DA851Q36622844-63212916-744B-4AD2-B228-A7390DFF0859Q36811179-E3855668-B5F0-432E-85CC-9270AF6FD276Q36815310-7BF7C71A-DAE3-44F7-A296-A50AD191BA01Q36815314-13C00FFD-6F8F-43A1-A1E2-6988B228FF50Q37211768-9C612BD4-0579-4D75-BBCE-94A56D2EEE48Q37447843-FCC88C64-F0D1-4C1C-8436-C18A6FAA8574Q37522921-A686F3BD-D73E-4F06-AED8-5566C3942BAEQ37983125-8F1D4EDD-75EB-4798-A93D-331E5D6A4853Q38040134-D4DDBA75-5FB9-43DE-864F-4661A75CBF1EQ38270101-EA51ECFB-D5C3-4B80-84B9-E18DA6F83B3FQ38695691-FCFF6DB0-6876-4CCB-9B15-AF2A908BBD6FQ39416809-E94D0606-7728-4ECB-8021-C45859A92AACQ39531951-651C59AE-6E76-43F3-9F0B-2B28AE2C7709Q40332441-60752311-0E57-42CE-889E-20A8F3D6AEA4Q40445770-3FBA7DCB-645F-496F-803D-BFD32DE72E5BQ40564718-6A3F6BD8-0CE4-4952-9506-B1E56CBD5804Q40636925-9494BD19-28D1-4F18-9FF3-70A546D72B92Q41682707-411B497B-D774-4433-A11C-8D43C37C64C2Q41885025-0C735BFC-BC20-4E1E-B3E1-A6CF6F21A15C
P2860
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
@ast
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
@en
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
@nl
type
label
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
@ast
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
@en
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
@nl
prefLabel
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
@ast
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
@en
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
@nl
P2860
P3181
P356
P1476
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
@en
P2093
J A Mitchell
T D Warner
P2860
P304
P3181
P356
10.1038/SJ.BJP.0702897
P407
P577
1999-11-01T00:00:00Z